Búsqueda | Biblioteca Virtual en Salud Fronteriza

1.

Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR⁺, HER2^- breast cancer that had progressed during or after prior endocrine therapy.

Musolino, Antonino; Campone, Mario; Neven, Patrick; Denduluri, Neelima; Barrios, Carlos H; Cortes, Javier; Blackwell, Kimberly; Soliman, Hatem; Kahan, Zsuzsanna; Bonnefoi, Hervé; Squires, Matthew; Zhang, Yong; Deudon, Stephanie; Shi, Michael M; André, Fabrice.

Breast Cancer Res ; 19(1): 18, 2017 02 10.

Artículo en Inglés | MEDLINE | ID: mdl-28183331

2.

Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: an open-label, randomised phase 3 trial.

Motzer, Robert J; Porta, Camillo; Vogelzang, Nicholas J; Sternberg, Cora N; Szczylik, Cezary; Zolnierek, Jakub; Kollmannsberger, Christian; Rha, Sun Young; Bjarnason, Georg A; Melichar, Bohuslav; De Giorgi, Ugo; Grünwald, Viktor; Davis, Ian D; Lee, Jae-Lyun; Esteban, Emilio; Urbanowitz, Gladys; Cai, Can; Squires, Matthew; Marker, Mahtab; Shi, Michael M; Escudier, Bernard.

Lancet Oncol ; 15(3): 286-96, 2014 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-24556040

3.

A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets.

Deng, Niantao; Goh, Liang Kee; Wang, Hannah; Das, Kakoli; Tao, Jiong; Tan, Iain Beehuat; Zhang, Shenli; Lee, Minghui; Wu, Jeanie; Lim, Kiat Hon; Lei, Zhengdeng; Goh, Glenn; Lim, Qing-Yan; Tan, Angie Lay-Keng; Sin Poh, Dianne Yu; Riahi, Sudep; Bell, Sandra; Shi, Michael M; Linnartz, Ronald; Zhu, Feng; Yeoh, Khay Guan; Toh, Han Chong; Yong, Wei Peng; Cheong, Hyun Cheol; Rha, Sun Young; Boussioutas, Alex; Grabsch, Heike; Rozen, Steve; Tan, Patrick.

Gut ; 61(5): 673-84, 2012 May.

Artículo en Inglés | MEDLINE | ID: mdl-22315472

4.

Phase I study of intravenous ASA404 (vadimezan) administered in combination with paclitaxel and carboplatin in Japanese patients with non-small cell lung cancer.

Hida, Toyoaki; Tamiya, Motohiro; Nishio, Makoto; Yamamoto, Nobuyuki; Hirashima, Tomonori; Horai, Takeshi; Tanii, Hiromi; Shi, Michael M; Kobayashi, Ken; Horio, Yoshitsugu.

Cancer Sci ; 102(4): 845-51, 2011 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-21205086

5.

BRAF polymorphisms and risk of melanocytic neoplasia.

James, Michael R; Roth, Richard B; Shi, Michael M; Kammerer, Stefan; Nelson, Matthew R; Stark, Mitchell S; Dumenil, Troy; Montgomery, Grant W; Hayward, Nicholas K; Martin, Nicholas G; Braun, Andreas; Duffy, David L.

J Invest Dermatol ; 125(6): 1252-8, 2005 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-16354196

6.

Technologies for individual genotyping: detection of genetic polymorphisms in drug targets and disease genes.

Shi, Michael M.

Am J Pharmacogenomics ; 2(3): 197-205, 2002.

Artículo en Inglés | MEDLINE | ID: mdl-12383026

7.

Activity of the fibroblast growth factor receptor inhibitors dovitinib (TKI258) and NVP-BGJ398 in human endometrial cancer cells.

Konecny, Gottfried E; Kolarova, Teodora; O'Brien, Neil A; Winterhoff, Boris; Yang, Guorong; Qi, Jingwei; Qi, Zhengdong; Venkatesan, Natarajan; Ayala, Raul; Luo, Tong; Finn, Richard S; Kristof, Jessica; Galderisi, Chad; Porta, Diana Graus; Anderson, Lee; Shi, Michael M; Yovine, Alejandro; Slamon, Dennis J.

Mol Cancer Ther ; 12(5): 632-42, 2013 May.

Artículo en Inglés | MEDLINE | ID: mdl-23443805

8.

Phase I/II and pharmacodynamic study of dovitinib (TKI258), an inhibitor of fibroblast growth factor receptors and VEGF receptors, in patients with advanced melanoma.

Kim, Kevin B; Chesney, Jason; Robinson, Douglas; Gardner, Humphrey; Shi, Michael M; Kirkwood, John M.

Clin Cancer Res ; 17(23): 7451-61, 2011 Dec 01.

Artículo en Inglés | MEDLINE | ID: mdl-21976540

9.

Prognostic and predictive role of lactate dehydrogenase 5 expression in colorectal cancer patients treated with PTK787/ZK 222584 (vatalanib) antiangiogenic therapy.

Koukourakis, Michael I; Giatromanolaki, Alexandra; Sivridis, Efthimios; Gatter, Kevin C; Trarbach, Tanja; Folprecht, Gunnar; Shi, Michael M; Lebwohl, David; Jalava, Tarja; Laurent, Dirk; Meinhardt, Gerold; Harris, Adrian L.

Clin Cancer Res ; 17(14): 4892-900, 2011 Jul 15.

Artículo en Inglés | MEDLINE | ID: mdl-21632858

10.

Diagnostics meets therapeutics: the impact of pharmacogenetics.

Shi, Michael M.

Drug Discov Today ; 7(23): 1161-2, 2002 Dec 01.

Artículo en Inglés | MEDLINE | ID: mdl-12547015

11.

Large-scale validation of single nucleotide polymorphisms in gene regions.

Nelson, Matthew R; Marnellos, George; Kammerer, Stefan; Hoyal, Carolyn R; Shi, Michael M; Cantor, Charles R; Braun, Andreas.

Genome Res ; 14(8): 1664-8, 2004 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-15289484

12.

Amino acid variant in the kinase binding domain of dual-specific A kinase-anchoring protein 2: a disease susceptibility polymorphism.

Kammerer, Stefan; Burns-Hamuro, Lora L; Ma, Yuliang; Hamon, Sara C; Canaves, Jaume M; Shi, Michael M; Nelson, Matthew R; Sing, Charles F; Cantor, Charles R; Taylor, Susan S; Braun, Andreas.

Proc Natl Acad Sci U S A ; 100(7): 4066-71, 2003 Apr 01.

Artículo en Inglés | MEDLINE | ID: mdl-12646697

Biblioteca Virtual en Salud Fronteriza

México - Estados Unidos

Su selección (0)

Formato de exportación:

Exportar: